AMERICAN JOURNAL OF CARDIOLOGY, cilt.94, sa.2, ss.206-209, 2004 (SCI-Expanded)
Hyperlipidemic patients with coronary heart disease were treated with atorvastatin, and its effects on hemostatic and inflammatory parameters were assessed. After 3 months of therapy, the plasma levels of plasminogen activator inhibitor, prothrombin fragment 1+2, highly sensitive C-reactive protein, von Willebrand factor, and fibrinogen were significantly reduced; no significant reductions were observed in lipoprotein(a) and tissue plasminogen activator antigen levels. (C) 2004 by Excerpta Medica, Inc.